Calendar of Events
Biotech Showcase™ 2022
2022 Program and Agenda
This year, the full Biotech Showcase family of events - Biotech Showcase, Digital Medicine and Medtech Showcase, China Showcase and Seed Showcase - will all take place concurrently at the Hilton San Francisco Union Square offering even greater convenience and collaboration opportunities while conveying the industry’s broad promise of innovation.
Medtech Connect Osaka 2022：The challenges to realising next generation therapeutics
Medtech Connect Osaka 2022 will bring together Japan’s thriving medtech ecosystem to discuss the future of the Pharmaceutical and Biotechnology industry. In specific we will seek to discuss the challenges in commercialising the newest therapeutics: from cell and gene therapies to regenerative medicine and mRNA. Join us as we explore the future of advanced therapy manufacturing practices, drug delivery, and n of 1 therapies.
The 2022 UK-Taiwan Digital Health Programme: Webinar
The 2022 UK-Taiwan Digital Health Webinar will offer valuable insights for UK companies and academia to learn about Taiwan’s market and regulatory landscape.
The webinar focuses on Taiwan's market and regulatory landscape, including 3 main topics:
- National Healthcare System
- The Digital Health Market Landscape
- An Overview of the Regulatory Environment
BIO CEO & Investor Conference
For more than 20 years, the BIO CEO & Investor Conference has fueled the biotech industry networking with premier investor and banking communities, focused on established and emerging publicly traded and select private biotech companies.
Join us in 2022 - either in person or online - for one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies, where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.
The Festival of Biologics
Biologics have completely transformed the way that patients are treated. Biologics don’t replace older medicines with newer medicines.
They increase the range of options for treatments, giving new opportunities for patients and their clinicians.
With three events in one, the Festival encourages conversation across the entire industry so you can inspire change, champion innovation, and address complex challenges that the biologics industry is facing.
The 2022 UK-Taiwan Digital Health Programme: B2B Matchmaking
The 2022 UK-Taiwan Digital Health Programme will offer valuable insights for UK companies and academia to learn about Taiwan’s market and regulatory landscape, which, along with matchmaking events, explore areas of joint interest, research, and links to commercial partners in Taiwan.
The B2B Matchmaking allows selected organizations in ICT, VC, Medical AIoT, MedTech, digital health, and research to identify prospective partners and create sustainable collaboration with the 1-1 partnering platform in real-time.
Asia Cell & Gene Therapy Innovation Summit 2022
-Cell Therapy Industrialization and Commercialization Module Strategy
-TCR-T Therapy Market Prospects and Development Trends
-Targets Selection and Direction of TCR-T Therapeutic Products
-Development Key Points of Universal CAR-NK Cell Therapy Products
-iPSC Personalized Diagnosis and Treatment and Application
-Research and Development of mRNA Drug and Delivery Vector Technology
-Viral Vector Process and Optimization Plan
-Difficulty in the Development of Gene Therapy Drugs for Rare Diseases
-Current Status of Circular RNA R&D
WSJ Health Forum
The pandemic triggered seismic shifts across the healthcare sector, from innovations in drug discovery, development and treatment to new approaches in patient care. As we combat new variants and slowly shift toward the pandemic-recovery phase, what are some of the lessons learned? How can we address the most pressing healthcare issues going forward?
Join us for WSJ Health Forum, taking place online on Tuesday, March 22, 2022. Hear from leaders with a wide range of perspectives and expertise as we look at what’s next for the business and science of health.
The sixteenth annual BIO-Europe Spring® 2022 conference will be held March 28-30 in Basel, Switzerland.
Over the last year, they launched this new way of partnering in the digital world and discovered its remarkable effectiveness in bringing the international life science community together to partner from anywhere in the world. That’s why their refreshed event approach will offer you two ways to attend BIO-Europe Spring® 2022.
First, their All-Access Pass will allow you to attend the event in person on March 28-30, participate in virtual one-to-one meetings on April 4-6, and gives you access to all on-demand content before and after the event.
Second, their Digital Access Pass will allow you to participate in virtual one-to-one meetings, April 4-6 and access on-demand content before and after the event. By marrying the best of the past with the new present, attendees can choose to partner onsite or digitally from home—gaining an equally valuable experience.
3rd Supply Chain & Logistics for Cell Therapies Summit
The only meeting uniting supply chain experts to advance the cell therapy supply chain and operations for seamless patient-led delivery is back and taking place in person for the first time!
Whilst cell therapies are changing the face of cancer treatments, a key challenge lies in having a resilient and patient-focused supply chain that remains robust throughout the commercialization process to ensure patient safety on a large scale.